We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EFPIA: Italy’s Endorsement of Off-Label Use Undermines EU Regulatory Framework
EFPIA: Italy’s Endorsement of Off-Label Use Undermines EU Regulatory Framework
Europe’s major pharma association is criticizing a decision by Italian regulators that would allow the government to pay for an off-label eye treatment, saying the move is motivated by cost savings and could undermine the EU’s regulatory authority.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor